Beyond administering CAR T-cell therapy and bispecifics, oncology nurses must apply proactive, supportive care and an understanding of complex treatments.

Notably, these data demonstrate that a nurse-led clinic could facilitate a system for patients to report their own symptom burden, where previous findings have demonstrated discrepancies exist between ...

Neurotoxicities can be monitored long term with personalized questions, according to Mary Steinbach, DNP, APRN.

The NCCN has added zongertinib to its guidelines for the care of patients with HER2 (ERBB2)-mutated non–small cell lung cancer.

BC, AOCNP, explained that adverse effects are common among the available antibody-drug conjugates in breast cancer.

In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in ...

Oncology nurses play a key role in monitoring, managing, and personalizing CDK4/6 inhibitor treatment to minimize toxicities ...

Barriers to CAR T-cell therapy exist for patients with multiple myeloma, even in urban areas, said Mary Steinbach, DNP, APRN, ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient ...

Panelists discuss how they guide first-line ALK inhibitor selection based on efficacy, tolerability, clinical data, and patient-specific considerations.